Other income lifts Aventis Pharma’s June qtr net

Other income lifts Aventis Pharma’s June qtr net

Mumbai: Drugmaker Aventis Pharma’s quarterly net profit beat forecast and rose 17% primarily on other income that more than doubled from a year ago.

The company’s other income stood 140 million, according to a statement.

The Mumbai-based drugmaker’s domestic revenue rose 12.1% to 244 crore during the quarter while exports rose 9.3% to 599 million, it said.

Acentis Pharma, a unit of France’s Sanofi , clocked a net profit of 497 million on net sales of 325 crore for April-June.

A Reuters poll of 17 brokerages had forecast a June quarter net profit of 467 million on net sales of 306 crore for Aventis.

At 3:17 p.m., shares of Aventis Pharma, which have gained 2.81% in April-June against BSE healthcare index that grew 6.21%, were trading at 2,099, down 1.84% in a weak Mumbai market.

Close